Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER) - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Hepatology Année : 2017

Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER)

Résumé

Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course
Fichier non déposé

Dates et versions

hal-03155282 , version 1 (05-03-2021)

Identifiants

Citer

S. Chevaliez, P. Trimoulet, C. Dorival, S. Larrat, C. Scholtes, et al.. Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER). Journal of Hepatology, 2017, 66 (1), pp.S84. ⟨10.1016/S0168-8278(17)30433-6⟩. ⟨hal-03155282⟩
31 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More